The Centers for Disease Control and Prevention (CDC) has been collaborating with global public health and industry partners to learn more about Omicron, and we are continuing to monitor its progress. We are still learning about the virus’s ability to spread, the severity of the disease it causes, and the effectiveness of the vaccines and drugs now available to combat it. The Omicron variation is more contagious than the original virus that causes COVID-19, as well as the Delta variant, which are both contagious. The Centers for Disease Control and Prevention (CDC) believes that anyone who has an Omicron infection can spread the virus to others, regardless of whether they have been vaccinated or whether they are experiencing symptoms.
According to research, the most prevalent symptoms caused by Omicron are very similar to those caused by other forms of the virus.
These are some examples:
- Cough
- Fever
- Congestion
- the presence of a runny nose
- Headache
- sore throat
Muscle soreness appears to be rather frequent as well. A dry cough and fever are also possible side effects of Omicron, although they are less common than with earlier forms. The majority of persons who become infected experience a dry sore throat, body aches, and a headache during the start of the infection. Those sensations continue to worsen for a few days. Omicron, on the other hand, appears to be associated with less loss of taste and smell. Severe lung diseases are also becoming less common.
Omicron is the coronavirus variety that has proven to be the most contagious so far, but it does not appear to be as lethal as previous versions such as Delta. According to the researchers, this is due to the fact that Omicron prefers to remain in the upper respiratory system rather than settling in the lungs, where it can cause more harm. Delta particles have been proven to settle down in the lungs and cause lung tissue damage considerably more quickly, resulting in pneumonia in laboratory animals. It is possible that the location of the virus’ residence is one of the primary reasons for the differences in symptoms.
Both disease severity and infection duration appear to be less severe in Omicron, particularly among those who have been vaccinated and boosted. However, despite the fact that some of these symptoms appear to be less severe, Omicron spreads significantly more swiftly, spreading up to three times as quickly as Delta. As a result, the number of people who have been infected has increased, as has the number of people who have come to the hospital for evaluation and treatment. Patients with Omicron disease are overrunning hospitals, indicating that the Omicron variation is not moderate in people who are unvaccinated, unboosted, or immunocompromised, as is the case in the general population.
COVID-19 vaccines continue to be the most effective public health measure available for protecting people against COVID-19 and reducing the likelihood of new variants emerging in the future. This comprises the initial series of shots, booster shots, and any further doses required by individuals who require them. In the meantime, scientists are still trying to figure out how effective different types of COVID-19 vaccines (jenis vaksin covid 19) are at preventing infection from Omicron infection. According to current expectations, current vaccines will protect against severe illness, hospitalizations, and deaths caused by infection with the Omicron strain. Breakthrough infections, on the other hand, are more likely to occur in people who have been vaccinated. People who are up to date on their COVID-19 vaccines and who receive COVID-19 are less likely to develop serious disease than people who are not up to date on their COVID-19 vaccines when they get COVID-19.
